Equities

Laboratorio Reig Jofre SA

Laboratorio Reig Jofre SA

Actions
  • Price (EUR)2.73
  • Today's Change0.02 / 0.74%
  • Shares traded52.20k
  • 1 Year change+9.64%
  • Beta0.4442
Data delayed at least 15 minutes, as of Sep 19 2024 16:13 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Share price forecast in EUR

The one analyst offering a 12 month price target expects Laboratorio Reig Jofre SA share price to rise to 233.00 in the next year from the last price of 2.77.
High8,311.6%233.00
Med8,311.6%233.00
Low8,311.6%233.00

Dividends

Historical dividend information is not available for Laboratorio Reig Jofre SA.
Div growth (TTM)--
More ▼

Earnings history & estimates in EUR

On Aug 08, 2012, losses of -0.04 per share. This result was in line with the expectation of the one analyst following the company
The next earnings announcement is expected on Feb 26, 2025.
Average growth rate+46.67%
Laboratorio Reig Jofre SA reported annual 2023 earnings of 0.118 per share on Feb 29, 2024.
Average growth rate+5.42%
More ▼

Revenue history & estimates in EUR

Laboratorio Reig Jofre, S.A. had revenues for the full year 2023 of 316.09m. This was 16.57% above the prior year's results.
Average growth rate+15.07%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.